Site Search
Search Results
Cancer Advocates to Convene on Beacon Hill to Urge Lawmakers to Reduce Health Disparities
... as a part of its annual Massachusetts state Lobby Day to urge them to support proposals that address the needs of cancer patients and reduce health disparities. Advocates will ask lawmakers to support legislation (House Bill 1227/Senate Bill 809) that would ensure insurance coverage ... testing and precision medicine due to financial barriers. Improving coverage for biomarker testing across insurance types will help reduce health disparities by eliminating these barriers. “Biomarker testing is essential to high-quality, personalized care for many conditions and can be a real gamechanger for many patients. Unfortunately, not everyone who can benefit from biomarker testing is ...
Cancer Advocates to Convene on Beacon Hill to Urge Lawmakers to Reduce Health Disparities
... as a part of its annual Massachusetts state Lobby Day to urge them to support proposals that address the needs of cancer patients and reduce health disparities. Advocates asked lawmakers to support legislation (House Bill 4339/Senate Bill 809) that would ensure insurance coverage of comprehensive biomarker testing. “Biomarker testing is essential to high-quality, personalized care for many conditions and can be a real gamechanger for many patients. Unfortunately, not everyone who can benefit from biomarker testing is ... that patients need,” said Marc Hymovitz, ACS CAN Massachusetts director of government relations. “There are significant disparities in health outcomes for Massachusetts patients by race, income, and insurance type. Without addressing barriers to care, like coverage of testing, ...
Expand Access to Biomarker Testing in Massachusetts
... and S.809 to guarantee coverage of evidence-based biomarker testing, so that every patient has a fair shot at the most effective, personalized care. Video of jung_as_biomarker_story What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment ... What are H. 4339 and S. 809, and why should Massachusetts pass them? H. 4339 and S. 809 would require MassHealth and state-regulated health insurance plans to cover biomarker testing when it is supported by strong clinical evidence and guidelines. As a global leader in life sciences and cancer research, Massachusetts has an opportunity to improve patient outcomes, advance health equity, and ensure that residents of the Commonwealth have access to the most effective, personalized medical care available. This is how we ...